Insider holders · CIK 0001875558
Nuvectis Pharma, Inc. · NVCT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Ron BentsurChairman & CEO | 3,688,424 | — | 3,688,424 | Jul 1, 2026 · 1:39 pm EDT | Form 4 |
| Marlio Charles Mosseri10% Owner | 109,321 | 3,186,576 | 3,295,897 | Jul 1, 2026 · 1:41 pm EDT | Form 4 |
| Michael J. CarsonVice President, Finance | 230,118 | — | 230,118 | Aug 5, 2026 · 5:26 pm EDT | Form 4 |
| Kenneth HobermanDirector | 168,140 | — | 168,140 | Jun 12, 2026 · 4:12 pm EDT | Form 4 |
| Matthew L. KaplanDirector | 159,760 | — | 159,760 | Jun 12, 2026 · 4:10 pm EDT | Form 4 |
| James F Oliviero IIIDirector | 122,828 | — | 122,828 | Jun 12, 2026 · 4:11 pm EDT | Form 4 |
| Juan SanchezDirector | 113,380 | 415 | 113,795 | Jun 12, 2026 · 4:11 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.